Salvianolic acid-A induces apoptosis, mitochondrial membrane potential loss and DNA damage in small cell lung cancer cell lines by Wang, L-Q et al.
Shaharuddin et al 
Trop J Pharm Res, August 2015; 14(8): 1399  
 
Tropical Journal of Pharmaceutical Research August 2015; 14 (8): 1399-1404 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v14i8.11 
Original Research Article 
 
 
Salvianolic Acid-A Induces Apoptosis, Mitochondrial 
Membrane Potential Loss and DNA Damage in Small Cell 
Lung Cancer Cell Lines 
 
Le-Qiang Wang1, De-Feng Hua2, Xiao-Meng Li1, Juan Li1 and Yun Guan1* 
1Department of Respiratory, Weifang People’s Hospital, 2Department of Neurology, Brain Hospital of Weifang People’s 
Hospital, Weifang 261599, China 
 
*For correspondence: Email: guanyun885@gmail.com, guanyun885@126.com; Tel/Fax: 0086-536-8192599 
 
Received: 6 January 2015        Revised accepted: 29 June 2015 
 
Abstract 
Purpose: To examine the anticancer effect of salvianolic acid-A against human small cell lung cancer 
(SCLC) cells (H-69).  
Methods: In vitro antiproliferative effect of salvianolic acid against SCLC cell lines was evaluated by 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptosis induction by 
salvianolic acid-A in these cells was measured by videomicroscopy along with fluorescence microscopy 
using Hoechst 33258 staining. The effect of the compound on mitochondrial membrane potential loss 
was detected by flow cytometry using rhodamine-123 as fluorescent probe. Gel electrophoresis was 
used to analyze DNA fragmentation after salvianolic acid treatment.  
Results: The results revealed that salvianolic acid-A induces dose-dependent as well as time-
dependent growth inhibitory effects against SCLC cancer cells. Videomicroscopy analysis revealed that 
SCLC cells became rounded (dead) and refringent after drug treatment which increased with increase in 
salvianolic acid-A dose.  Fluorescence microscopy demonstrated that salvianolic acid-A induced dose-
dependent chromatin condensation in SCLC cells which is characteristic of apoptosis. DNA 
fragmentation was induced by various doses of the compound again hinting at apoptosis. Flow 
cytometry analysis using rhodamine-123 showed that salvianolic acid-A also caused substantial loss of 
mitochondrial membrane potential. 
Conclusion: The results suggest that salvianolic acid-A is a potential anticancer and apoptotic agent 
against drug-resistant small cell lung cancer.   
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Lung cancer is believed to be one of the most 
lethal carcinomas in the world [1,2]. In China, 
about 320, 000 people died in 2005 because of 
lung cancer. There has been a large increase in 
the number of lung cancer cases in the last 
decade compared to the early 1990s [3]. Small 
cell lung cancer (SCLC) comprises 
approximately 12 % of all lung cancers detected. 
SCLC is a highly malignant tumor of the lung and 
due to its rapid growth and development of drug 
resistance, its treatment still remains a tough 
task and challenge for scientists [4]. 
 
Chemotherapy is the main treatment strategy in 
both primary and palliative care of patients with 
lung cancer. Many patients with SCLC do not 
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respond to such chemotherapy, or they respond 
well initially and then slowly decline. This may 
lead to an increase in the drug dosage, which 
generally increases the adverse effects, without 
improving the clinical outcome. In contrast to 
non-small cell lung cancer (NSCLC), small cell 
lung cancer cells (SCLC) can acquire resistance 
with prolonged use of the anticancer drugs [5]. 
Additionally, majority of the patients with lung 
cancer already have reached metastatic stage at 
the time of diagnosis making it difficult to use 
other treatment regimens like surgery and 
radiotherapy. If left untreated, SCLC has the 
most belligerent clinical course of any type of 
pulmonary tumor, with average survival from 
diagnosis of only 2 to 4 months [6]. 
 
Keeping in view the limited treatment options 
available for small cell lung cancer coupled with 
the menace of drug resistance which is rampant 
in most SCLC cancers, the objective of the 
present research work was to evaluate 
salvianolic acid, a natural product, for its 
anticancer effects against the human SCLC cell 
line NCI-H69 (H69). We studied its effect on 
apoptosis induction, DNA damage and 
mitochondrial membrane potential loss in these 
cell lines using fluorescence microscopy, gel 
electrophoresis and flow cytometry. The 
compound exhibited dose-dependent as well as 
time-dependent antiproliferative effects against 
this multidrug resistant cell line. The results are 
encouraging since this cell line is highly resistant 
to most anticancer drugs and as such, salvianolic 




Cell lines and chemicals 
 
Human SCLC cell line NCI-H69 (H - 69) was 
procured from Shanghai Institute of Biochemistry 
and Cell Biology (Shanghai, China). Cells were 
cultured in RPMI 1640 with 10 % fetal bovine 
serum (Hyclone Laboratories, Logan, UK) and 
100 units/ml penicillin -100 µg/Ll streptomycin, 
and were grown at 37 °C in a humidified 95 % air 
and 5 % CO2 atmosphere. RPMI 1640 and other 
culture materials were from GIBCO/BRL Life 
Technologies (Grand Island, NY). Salvianolic 
acid A (> 95 % purity by HPLC) was purchased 
from Sigma Chemical Co. (St. Louis, MO.).  
 
Cell proliferation assay using MTT  
 
Cell proliferation was determined by MTT assay. 
Human SCLC cells (H-69) in exponential growth 
were seeded at a final concentration of 5 × 105 
cells/mL in a 96‑well plate. At 50 % confluence, 
the cells were pretreated with salvianolic acid A 
at various concentrations (0, 5, 10, 20, 40, 80 
and 100) for 24 h. Ten microliters of MTT 
solution (1 mg/mL in PBS) was added to each 
well and the cells were cultured for another 4 h at 
37 oC. The medium was completely removed and 
200 μL DMSO was added to solubilize MTT 
formazan crystals. The plates were then agitated 
and the optical density was determined at 570 
nm (OD570) using an ELISA plate reader (Model 
550; Bio‑Rad, Hercules, CA, USA). At least three 
independent experiments were performed. 
 
Computer-assisted phase contrast 
microscopy (quantitative videomicroscopy) 
 
As described in previous studies [7,8], the 
salvianolic acid A-induced cytotoxic effects 
against the human SCLC cells (H - 69) were 
directly visualized using quantitative 
videomicroscopy. This experiment involving 
computer-assisted phase contrast microscopy 
was developed to capture digital images of the 
cell culture at a different treatment 
concentrations (0, 10, 50 and 100 µM) for a 
period of 48 h thus providing 1200 high quality 
images that can be watched as running movies 
of few minutes length. 
 
Nuclear staining with Hoechst 33258 for cell 
morphology study 
 
Human SCLC cells (H-69, 1 × 105 cells/dish) 
were plated in 6-cm dish and then treated with or 
without salvianolic acid A (concentrations used 
were 0, 10, 50 and 100 µM). After 48 h 
incubation, the harvested cells were washed with 
PBS and fixed with 1 % glutaraldehyde for 20 
min. After this the cells were stained with 
Hoechst 33258 for 10 - 12 min. The cells were 
again washed with PBS and then observed by 
fluorescence microscope (Olympus, Olympus 
Optical Co., LTD, Tokyo, Japan) using UV filter 
at x40 magnification. 
 
Flow cytometry analysis of the mitochondrial 
membrane potential (ΔΨm) 
 
The effect of salvianolic acid A on mitochondrial 
membrane potential in human SCLC cells was 
detected by using rhodamine-123 (2 mM) 
fluorescent probe. This probe aids in measuring 
membrane polarization in live cell mitochondria.  
The SCLS cells (5 × 106 cells/dish) were treated 
with different concentrations of salvianolic acid A 
(0, 10, 50 and 100 µM) for 48 h and 
mitochondrial membrane potential was measured 
by flow cytometry using BD FACSCalibur flow 
cytometer and Cell Quest software 3.0 (Becton-
Dickinson). Rhodamine-123 (2 mM) was added 2 
h before the termination of experiment. Cells 
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were collected, washed in PBS, and incubated 
with propidium iodide (20 µg/mL) for 20 min.  
 
Analysis of DNA fragmentation after 
salvianolic acid-A treatment 
 
The SCLC cells (5 × 105 cells/dish) were plated 
in 6-cm dish and then subjected to treatment with 
different concentrations of salvianolic acid A. 
After drug treatment, the cells were washed with 
ice-cold PBS and resuspended in lysis buffer (25 
mM Tris-HCl, pH 7.4, 5 mM EDTA and 0.6 % 
SDS) with 0.5 mg/mL RNase A for 20 min at 50 
oC. After this proteinase K was added and then 
the cells were incubated overnight. Separation of 
DNA was done using 2 % agarose gel and the 
DNA was detected under UV light after staining 




All data were derived from at least three 
independent experiments. The results are 
expressed as mean ± SD in all conditions. 
Differences between groups were analyzed using 





Antiproliferative activity of salvianolic acid-A 
against SCLC cells 
 
The antiproliferative activity of salvianolic acid-A 
is shown in Fig. 1. The compound exhibited 
dose-dependent as well as time-dependent 
antiproliferative effects against this multidrug 
resistant cell line. The results are encouraging 
since this cell line is highly resistant to most 
anticancer drugs and such salvianolic acid can 




The limitation of the MTT assay is that it does not 
inform us whether a compound reduces the 
growth of cancer cells through cytostatic or 
cytotoxic effects or a cumulative effect of several 
of these effects. Quantitative videomicroscopy or 
computer-assisted phase contrast microscopy 
allows us to differentiate between these different 
kinds of growth inhibitory effects of salvianolic 
acid-A against SCLC cells. The results of this 
experiment are shown in Fig. 2 A-D. Cells that 
died appeared rounded and refringent under 
quantitative videomicroscopy analysis. The 
proportion of this cell type in SCLC cells was 
higher following treatment with salvianolic acid at 
higher doses (B, C and D represent 10, 50 and 
100 µM concentration of salvianolic acid-A) 
indicating higher cell death at higher 
concentration of salvianolic acid-A. The results of 
this experiment showed that salvianolic acid-A 
exerted cytostatic effects and not cytotoxic 
effects against these cells. Indeed, salvianolic 
acid-A induced marked vacuolization processes, 




Figure 1: Antiproliferative effect of the different doses of salvianolic acid-A on the SCLC cells at three different 
time intervals (12 h, 24 h and 48 h) 
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Effect of salvianolic acid-A on apoptosis 
induction in SCLC cells 
 
In order to evaluate whether the salvianolic acid-
A induced anticancer effects against SCLC cells 
was due to associated apoptosis, we evaluated 
the effect of salvianolic acid-A on nuclear 
morphology using Hoechst 33258 staining. Fig. 3 
A, represents untreated cells which showed 
normal nuclear morphology, Fig. 3B-D represent 
10, 50 and 100 µM doses of salvianolic acid-A 
respectively. The salvianolic acid-A treated cells 
showed dose dependent chromatin condensation 




Figure 2: Quantitative videomicroscopy analysis salvianolic acid A for the human small cell lung cancer cancer 
cell line (H-69). The morphological analyses were carried out at a X100 magnification. The arrows show rounded 
cells which represent the dead cells. (A)represents untreated cells; (B) represents 10 µM, (C)represents 50 µM 




Figure 3: Effect of salvianolic acid-A on apoptosis induction (chromatin condensation) in human small cell lung 
cancer cells. SCLC cells were treated with 0 µM (A), 10 µm (B), 50 µm (C) and 100 µm (D) respectively for 48 h 
and stained with Hoechst 33258. The nuclear morphology was observed by fluorescent microscopy 
(magnification 400×). Arrows represent nuclear chromatin condensation 
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Effect of salvianolic acid-A on DNA 
fragmentation in SCLC cells 
 
The effects of the salvianolic acid-A on DNA 
fragmentation and hence on the apoptosis 
induction are shown in Fig. 4. DNA fragmentation 
was analyzed based on DNA laddering using 
agarose gel electrophoresis. Fig. 4 shows that 
salvianolic acid-A treatment led to the 
appearance of the DNA ladder in a dose-
dependent manner. M is the 100-bp DNA 
marker. DNA fragmentation is a key event in the 




Figure 4: Induction of DNA fragmentation by 
salvianolic acid-A in human SCLC cells. The cells 
were treated with salvianolic acid at various 
concentrations (0, 10, 50 and 100 µM) for 48 h, and 
the DNA fragmentation was analyzed by agarose gel 
electrophoresis. M is the 100-bp DNA marker 
 
Effect of salvianolic acid-A on the 
mitochondrial membrane potential in SCLC 
cells 
 
The results of the effect of salvianolic acid-A on 
mitochondrial membrane potential are shown in 
Fig. 5 A-D. As can be seen in Fig. 5, salvianolic 
acid induced concentration-dependent loss of 
mitochondrial membrane potential in SCLC cells. 
The number of cells with intact mitochondrial 
membrane potential decreased considerably 
while as the number of cells with decreased 
mitochondrial membrane potential increased. 




Figure 5: Salvianolic acid-A induced loss of 
mitochondrial membrane potential in SCLC cancer 
cells. A, represents untreated cells, B, C and D, 





Salvianolic acid A is the most abundant, water-
soluble and an effective compound extracted 
from Salvia miltiorrhiza (Danshen) which has 
been used in the treatment of various diseases. 
In China, Danshen has been wildly used to treat 
various diseases for hundreds of years. 
Salvianolic acids, especially salvianolic acid A 
and salvianolic acid B, have been found to have 
potent anti-oxidative capabilities due to their 
polyphenolic structure [9,10]. Salvianolic acid-A 
has been reported to exhibit anti-platelet 
aggregation and anticancer properties. It has 
also been reported that combination of 
salvianolic acid-A with other known anticancer 
agents like 5-fluorouracil, mitomycin C and 
methotrexate led to a potent cancer growth 
inhibition [11,12]. Preliminary data have indicated 
that salvianolic acid-A is able to inhibit cancer 
growth in mouse models, including liver, breast 
and lung cancers. The mechanism of action of 
salvianolic acid-A in the regulation of cancer cell 
growth has yet to be elucidated. 
 
The objective of the current research work was to 
elucidate the molecular mechanism of action of 
salvianolic acid-A against small cell lung cancer 
cells. We studied the effect of salvianolic acid-A 
on apoptosis induction using computer-assisted 
phase contrast microscopy as well as 
fluorescence microscopy. These assays 
demonstrated how this compound affects nuclear 
chromatin condensation and overall cellular 
morphology. Gel electrophoresis indicated that 
salvianolic acid induced dose-dependent DNA 
Shaharuddin et al 
Trop J Pharm Res, August 2015; 14(8): 1404  
 
damage in these cells. Flow cytometry analysis 
using rhodamine-123 fluorescent probe revealed 
that salvianolic acid induces potent loss in 





This work reveals, probably for the first time, the 
molecular mechanism of salvianolic acid-A 
against small cell lung carcinoma. The 
compound induces potent growth inhibitory and 
apoptotic effects against this cell line. Therefore, 
salvianolic acid-A has the potential to be 
developed as an anticancer agent against this 
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